| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.8 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |